blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2207879

EP2207879 - IDENTIFICATION AND ISOLATION OF FETAL CELLS AND NUCLEIC ACID [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.01.2015
Database last updated on 28.09.2024
Most recent event   Tooltip16.01.2015Application deemed to be withdrawnpublished on 18.02.2015  [2015/08]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2012/15]
Former [2010/29]For all designated states
Biocept, Inc.
5810 Nancy Ridge Drive, Suite 150
San Diego, CA 92121 / US
Inventor(s)01 / BISCHOFF, Farideh
3314 N. Briarpark Lane
Sugar Land Texas 77479 / US
 [2010/29]
Representative(s)Clegg, Richard Ian
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2010/29]Clegg, Richard Ian
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date08831741.722.09.2008
[2010/29]
WO2008US77251
Priority number, dateUS20070974392P21.09.2007         Original published format: US 974392 P
[2010/29]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009039507
Date:26.03.2009
Language:EN
[2009/13]
Type: A2 Application without search report 
No.:EP2207879
Date:21.07.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 26.03.2009 takes the place of the publication of the European patent application.
[2010/29]
Search report(s)International search report - published on:KR18.06.2009
(Supplementary) European search report - dispatched on:EP30.12.2010
ClassificationIPC:C12N15/09, C07K16/28, G01N33/53, C12Q1/68, G01N33/50, G01N33/68
[2011/04]
CPC:
G01N33/6875 (EP,KR); G01N33/5044 (EP,KR); C07K16/18 (KR);
G01N33/5091 (EP,KR); G01N33/5302 (KR); G01N33/533 (KR);
G01N33/689 (EP,KR); G01N2333/4703 (EP,KR) (-)
Former IPC [2010/29]C12N15/09, C07K16/28, G01N33/53, C12Q1/68
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/29]
TitleGerman:IDENTIFIZIERUNG UND ISOLIERUNG FÖTALER ZELLEN UND NUKLEINSÄURE[2010/29]
English:IDENTIFICATION AND ISOLATION OF FETAL CELLS AND NUCLEIC ACID[2010/29]
French:IDENTIFICATION ET ISOLEMENT DE CELLULES ET D'ACIDE NUCLÉIQUE F TAUX[2010/29]
Entry into regional phase14.04.2010National basic fee paid 
14.04.2010Search fee paid 
14.04.2010Designation fee(s) paid 
14.04.2010Examination fee paid 
Examination procedure14.04.2010Examination requested  [2010/29]
07.07.2011Amendment by applicant (claims and/or description)
07.05.2014Despatch of a communication from the examining division (Time limit: M04)
18.09.2014Application deemed to be withdrawn, date of legal effect  [2015/08]
10.10.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/08]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.05.2014
Fees paidRenewal fee
29.09.2010Renewal fee patent year 03
29.09.2011Renewal fee patent year 04
12.09.2012Renewal fee patent year 05
12.09.2013Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.09.201407   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XPI]WO2007121276  (BIOCEPT INC [US], et al) [XP] 1-10,12-16,21,22,26,29-33 * the whole document *[I] 11,17-20,23-25,27,28
International search[X]US2004197832  (AMIEL ALIZA [IL], et al);
 [X]US2005181429  (FEJGIN MOSHE D [IL], et al);
 [A]US2006041946  (FISHER ADAMA G [GB]);
 [XP]US2007243549  (BISCHOFF FARIDEH Z [US]);
 [Y]  - GODFRIED W. VAN DER HEIJDEN ET AL., "Asymmetry in histone H3 variants and lysine methylation between paternal and maternal chromatin of the early mouse zygote.", MECHANISMS OF DEVELOPMENT., (200509), vol. 122, no. 9, pages 1008 - 1022, XP025329302

DOI:   http://dx.doi.org/10.1016/j.mod.2005.04.009
by applicantWO2007121276
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.